mazetx.comHealthcare / Healthcare softwareFounded: 2018Funding to Date: $767.8MM
Maze Therapeutics is a biotechnology company focused on developing novel therapeutics to treat genetic diseases. The company's mission is to address the underlying genetic causes of disease and enable the development of targeted therapies that can improve patients' lives.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
01/10/2022 | Series C | $120.62MM | $xx.xx | $742.72MM | Matrix Capital Management, General Catalyst, Andreessen Horowitz, Woodline Partners, Casdin Capital, City Hill Ventures, Foresite Capital, Direhaus Capital Management, Moore Strategic Ventures, Terra Magnum Capital Partners, NS Investments | |
Price per Share
$xx.xx
Shares Outstanding
40,866,704
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Matrix Capital Management, General Catalyst, Andreessen Horowitz, Woodline Partners, Casdin Capital, City Hill Ventures, Foresite Capital, Direhaus Capital Management, Moore Strategic Ventures, Terra Magnum Capital Partners, NS Investments
|
||||||
10/25/2019 | Series B | $158.3MM | $xx.xx | $596.01MM | City Hill Ventures | |
Price per Share
$xx.xx
Shares Outstanding
57,563,188
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
City Hill Ventures
|
||||||
02/28/2019 | Series A | $104.99MM | $xx.xx | $149.98MM | Third Rock Ventures, ARCH Venture Partners, GV, Foresite Capital, Casdin Capital, Alexandria Venture Investments | |
Price per Share
$xx.xx
Shares Outstanding
104,985,132
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Third Rock Ventures, ARCH Venture Partners, GV, Foresite Capital, Casdin Capital, Alexandria Venture Investments
|